Horchata Emerges as the Next Beverage Trend Challenging Matcha and Bubble Tea in the UK Market EU and Mexico Sign Updated Trade Deal to Reduce Reliance on US and China VinFast Names Founders Son as New CEO in Strategic Recalibration of Global EV Expansion Bitcoin Price Pattern Echoes 2022 Downturn With Intensified Decline Mutual Fund SIPs Over OneThird of 2Year Investments Show Losses Data Reveals Chennai PortMaduravoyal Elevated Corridor Targets November 2027 Completion Addex Therapeutics Q1 2024 Earnings PreRevenue Biotech Advances Pipeline Amid Narrowing Losses PLBY Q1 2026 Earnings EPS Misses Estimates Amidst Ongoing Challenges GAP Q1 2026 Earnings EPS Slightly Misses Estimates Amid Challenging Retail Environment NTNX Q1 2026 Earnings EPS Surges Past Estimates Driving Shares Higher BMEA Q1 2026 Earnings Narrower Loss Beats Expectations as Clinical Progress Continues BWBBP Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Lower UFP Technologies UFPT Holds Above Support After Modest Decline Focus Shifts to Resistance Sphere 3D Corp ANY Slips 2 as Broader Market Pressure Weighs on Bitcoin Mining Stock Valley National Bancorp Preferred Stock VLYPO Holds Steady Near 2512 Key Support and Resistance in Focus AppFolio Shares Slide 26 as Selling Pressure Intensifies Near Resistance PayPay PAYP Slips 155 as Shares Test Key Support Levels CPF LIFE vs SelfInvesting Retirement Decision Hinges on Financial Management in Old Age CLST Q3 2025 Earnings Net Income Strengthens Amid Steady Operational Focus LifeMD LFMD Rebounds 75 on Improved Volume Testing Resistance at 479 SpaceXs Potential SP Sector Classification A Multifaceted Challenge RBIs 25 bps Rate Cut Raises Questions on Policy Framework Nomura Suggests South Koreas Galaxy Robot Park Aims to Merge KPop and Robotics to Redefine Entertainment Tourism Rigetti Computing Stock Surges on 100 Million Government Backing Report SpaceX Starship Test Could Influence Anticipated IPO Market Watchers Say Housing and Climate Resilience Top Latin American Agenda at World Urban Forum 13 Eli Lillys Retatrutide Shows Strong Phase 3 Data Adding WeightLoss Pipeline Momentum